Flurry of Acquisitions and Licensing Deals Come Amid JP Morgan Healthcare Conference 2025

Estimated read time 1 min read

Organizations including Gilead, Eli Lilly, and AbbVie announced a number of deals addressing inflammatory diseases, multiple myeloma, and other disease areas.

You May Also Like

More From Author

+ There are no comments

Add yours